XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 42 filers reported holding XENON PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $9,837,000 | +18.7% | 272,500 | 0.0% | 4.24% | -8.3% |
Q2 2022 | $8,289,000 | +20.5% | 272,500 | +21.1% | 4.62% | +43.7% |
Q1 2022 | $6,878,000 | -2.1% | 225,000 | 0.0% | 3.21% | +8.8% |
Q4 2021 | $7,029,000 | +10.2% | 225,000 | -46.1% | 2.96% | +31.3% |
Q3 2021 | $6,378,000 | -17.9% | 417,409 | 0.0% | 2.25% | -27.6% |
Q2 2021 | $7,772,000 | +5.3% | 417,409 | +1.2% | 3.11% | +16.7% |
Q1 2021 | $7,384,000 | +500.3% | 412,500 | +415.6% | 2.66% | +694.6% |
Q4 2020 | $1,230,000 | -63.0% | 80,000 | -73.3% | 0.34% | -62.9% |
Q3 2020 | $3,321,000 | -48.8% | 300,000 | -42.0% | 0.90% | -51.9% |
Q2 2020 | $6,489,000 | -9.0% | 517,500 | -17.7% | 1.88% | -45.7% |
Q1 2020 | $7,127,000 | -40.7% | 628,500 | -31.5% | 3.45% | +15.9% |
Q4 2019 | $12,028,000 | +90.0% | 917,500 | +30.6% | 2.98% | -34.8% |
Q3 2019 | $6,330,000 | -8.5% | 702,500 | +0.1% | 4.57% | +85.7% |
Q2 2019 | $6,917,000 | +23.2% | 701,500 | +27.0% | 2.46% | -7.8% |
Q1 2019 | $5,613,000 | +65.5% | 552,500 | +2.8% | 2.67% | +3.2% |
Q4 2018 | $3,392,000 | -46.7% | 537,500 | +11.4% | 2.59% | +13.9% |
Q3 2018 | $6,369,000 | +53.8% | 482,500 | +7.2% | 2.27% | +208.3% |
Q2 2018 | $4,140,000 | – | 450,000 | – | 0.74% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 1,594,932 | $48,518,000 | 10.26% |
GREAT POINT PARTNERS LLC | 1,104,334 | $33,594,000 | 8.06% |
ACUTA CAPITAL PARTNERS, LLC | 272,500 | $8,289,000 | 4.62% |
DAFNA Capital Management LLC | 438,623 | $13,343,000 | 3.64% |
Parkman Healthcare Partners LLC | 294,559 | $8,960,000 | 3.30% |
Avoro Capital Advisors LLC | 4,900,000 | $149,058,000 | 2.94% |
Nan Fung Group Holdings Ltd | 114,380 | $3,479,000 | 2.39% |
BVF INC/IL | 1,597,966 | $48,610,000 | 2.35% |
SILVERARC CAPITAL MANAGEMENT, LLC | 232,630 | $7,077,000 | 2.18% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 4,391,038 | $133,575,000 | 2.16% |